SEC Form 4 · accession 0001209191-16-109633
ANTARES PHARMA, INC. · ATRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James E Fickenscher
Officer — Senior Vice President & CFO
Period of report
Mar 18, 2016
Accepted (ET)
Mar 21, 2016 · 9:13 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 18, 2016 | P | 135,000 | $0.72 | A | 270,216 | D |
Table II — derivative securities
No Table II lines on this filing.